Please find all related articles below.
On the occasion of 2013 Patients’ Rights Day (May 15) EPHA would like to stress that, although much progress has been made, there is still a lot of scope for health systems to benefit from an obvious, yet commonly underutilized and underestimated resource: patients themselves.
As patients and consumers of health services - and we all fall into this category throughout our lives - we build up an enormous amount of knowledge over the years that takes various forms. Some individuals, (...)
While generally speaking, political change in Brussels tends to be tremendously slow, twenty years are a sufficiently long period of time to have witnessed some crucial changes in the continent’s public health sphere.
At the time of EPHA’s inception in 1993, Article 129 of the Maastricht Treaty had just equipped the European Commission with a limited but important legal coordinating role in the field of public health with a focus on prevention, health promotion and protection. (...)
Brussels, 3 May – Today, the Scottish Government has won a case on Minimum Unit Pricing (MUP) for alcohol (1) in the Scottish High Court - the first legally-binding minimum price on alcohol within the EU. Now the alcohol industry will have 21 days to decide whether it has grounds for appeal.
MUP sets a floor price below which alcohol cannot be legally sold and unlike taxation, MUP prices alcoholic beverages based on their strength.
Alcohol misuse hits the poor badly, most of whom (...)
On 4 and 5 September 2013 the European Public Health Alliance (EPHA) will celebrate 20 years of helping shape Europe’s public health. EPHA is using this milestone as an opportunity to look at how we can foster an EU that is coherent in its decisions, in terms of fostering the health and well-being of people living in Europe.
Brave New World: Inclusive Growth and Well-Being or Vested Interests and Lost Generations?
Vytenis Povilas Andriukaitis, Lithuanian (...)
Health in all policies
The European Observatory on Health Systems and Policies and the Veneto Region of Italy are organising a Summer School with the title â€œTime for Change: Innovative Ways of Improving Population Healthâ€
The European Observatory on Health Systems and Policies and the Veneto Region of Italy are organising a Summer School with the title “Time for Change: Innovative Ways of Improving Population Health”
European countries increasingly recognize the importance of (...)
As one of the deliverables of the pharmacovigilance legislation, that came into effect in July 2012, the European Medicines Agency (EMA) released an initial list of drugs subject to additional monitoring on 25 April 2013.
Please click here to read the full EMA Press Release, which contains additional information.
How to identify them?
Medicines subject to additional monitoring will have to display an inverted back triangle in their package leaflet and in the information for healthcare (...)
Glenis Willmott MEP (S&D, UK) took the initiative to bring together experts to discuss the extent to which more transparency could be workable in non-commercial clinical trials. The debate, which took place in the European Parliament on 10 April, served to present the key arguments for and against increased transparency in the context of administrative and data reporting requirements for academic researchers and patient safety.
EPHA’s Position on Clinical Trials urges political (...)
Pharmaceuticals and Medicines
Health Rights and Patients
You are cordially invited to join Alex Neil, Scottish Cabinet Secretary for Health and Well-being & representatives from governments, non-governmental organisations, leading academics and Members of the European Parliament for an EVENING RECEPTION and European launch of Alcohol and cancer: a report from the Royal College of Physicians (RCP) and the Alcohol Health Alliance UK (AHA).
European Parliament (Brussels) 24 April 2013, from 19:00
Co-hosted by Rebecca Taylor MEP (UK, ALDE) (...)
Medical devices and in vitro diagnostic medical devices.
The term “medical device” covers an extremely diverse range of healthcare instruments – from simple bandages and dressings to tongue depressors, medical thermometers and blood sugar meters to pacemakers and life-supporting products, as well as eHealth devices which communicate remotely.
The medical devices industry constitutes a key sector for healthcare. It is one of the most dynamic sectors, improving and saving (...)
The Europe 2020 Strategy was launched in 2010 to promote ‘smart, sustainable and inclusive growth’. It sets targets for employment, innovation, climate and energy policy, education and social inclusion, most of which are in some way related to health policies and priorities. For example, public health has clear implications for work hours, labour force participation, early retirement, and health and safety at work, and these factors impact on health.
In the Annual Growth Survey (...)